yingweiwo

GPR

GPR

GPR related products

Structure Cat No. Product Name CAS No. Product Description
GPR84 agonist-1 V86633 GPR84 agonist-1 489403-70-5 GPR84 agonist-1 (Compound LY214-5) is a GPR84 agonist with EC50 of 2.479 μM.
GPR84 agonist-2 V136879 GPR84 agonist-2 3105662-82-3 GPR84 agonist-2 is a selective GPR84 agonist that is inactive against free fatty acid receptors.
GPR84 antagonist 1 V75420 GPR84 antagonist 1 2762180-28-7 GPR84 antagonist 1 is a high-affinity, selective competitive antagonist of human GPR84.
GPR84 antagonist 10 V136880 GPR84 antagonist 10 2654791-94-1 GPR84 antagonist 10 is a potent and orally effective GPR84 antagonist.
GPR84 antagonist 2 V75418 GPR84 antagonist 2 2244269-74-5 GPR84 antagonist 2 (compound 33) is an orally bioactive, selective GPR84 antagonist (IC50=8.95 nM).
GPR84 antagonist 3 V75421 GPR84 antagonist 3 2815263-05-7 GPR84 antagonist 3 (compound 42) is a potent GPR84 (G protein-coupled receptor 84) antagonist.
GPR84 antagonist 9 V86632 GPR84 antagonist 9 2654791-96-3 GPR84 antagonist 9 is an orally active GPR84 antagonist with IC50 of 0.012 μM.
GPR88 agonist 2 V75423 GPR88 agonist 2 2821859-71-4 GPR88 agonist 2 (compound 53) is a potent, BBB (blood-brain barrier) permeable (penetrable) GPR88 agonist/activator with EC50 of 14 nM in GPR88 cAMP functional assays.
GPR88 agonist 3 V85742 GPR88 agonist 3 2963597-44-4
GPR88-IN-1 V75422 GPR88-IN-1 714265-50-6 GPR88-IN-1 is a GPR88 inhibitor that may be utilized in the research/study of central diseases.
GSK1292263 V1804 GSK1292263 1032823-75-8 GSK1292263 is a novel and potentGPR119 (G-protein-coupled receptor 119) agonist whichhas potential for the treatment of type 2 diabetes.
GW856464 V137028 GW856464 851690-21-6 GW856464 is an antagonist of MCHR1.
GW9508 V1805 GW9508 885101-89-3 GW9508 is a novel, potent and selective agonist for FFA1 (fatty acid receptor GPR40) with pEC50 of 7.32, and is 100-fold selective against GPR120, it stimulates insulin secretion in a glucose-sensitive manner.
HEP-50768 V137266 HEP-50768 3036387-75-1 HEP-50768 is an orally effective selective MRGPRX4 (hX4) antagonist.
hMCH-1R antagonist 1 V70560 hMCH-1R antagonist 1 353487-64-6 hMCH-1R antagonist 1 (Compound 30) is a potent and specific human melanin concentrating hormone receptor 1 (hMCHR1) antagonist (inhibitor) with a KB of 3.6 nM.
K-833 V138336 K-833 2639936-77-7 K-833 is a GPR119 agonist with EC50 values of 39.8 nM in humans, 100 nM in mice, 75.4 nM in rats, and 12.6 nM in dogs.
L-α-lysophosphatidylinositol (Soy) (sodium) V70310 L-α-lysophosphatidylinositol (Soy) (sodium) 796963-91-2 L-α-lysophosphatidylinositol Soy sodium is the endogenous ligand of GPR55.
MCH-1 antagonist 2 V139515 MCH-1 antagonist 2 345-24-4 MCH-1 antagonist 2 is a melanin-concentrating hormone-1 (MCH1) receptor-selective 4-arylpiperidine.
MrgprX2 antagonist-10 V140399 MrgprX2 antagonist-10 3116848-78-0 MrgprX2 antagonist-10 is a MrgprX2 antagonist with an IC50 of less than 100 nM.
MrgprX2 antagonist-11 V140400 MrgprX2 antagonist-11 3116847-13-0 MrgprX2 antagonist-11 is a MrgprX2 antagonist with an IC50 of less than 100 nM.
Contact Us